GIANNATEMPO, PATRIZIA
 Distribuzione geografica
Continente #
EU - Europa 625
NA - Nord America 515
AS - Asia 120
SA - Sud America 5
Totale 1.265
Nazione #
US - Stati Uniti d'America 510
GB - Regno Unito 213
DE - Germania 194
IT - Italia 77
CN - Cina 62
SE - Svezia 62
IE - Irlanda 21
BE - Belgio 13
FI - Finlandia 13
KR - Corea 13
SG - Singapore 12
FR - Francia 10
IN - India 10
HK - Hong Kong 8
JP - Giappone 5
TR - Turchia 5
UA - Ucraina 5
CA - Canada 4
NL - Olanda 4
BR - Brasile 3
DK - Danimarca 3
AT - Austria 2
GR - Grecia 2
NO - Norvegia 2
PL - Polonia 2
PT - Portogallo 2
VN - Vietnam 2
AR - Argentina 1
EC - Ecuador 1
ID - Indonesia 1
IL - Israele 1
MX - Messico 1
MY - Malesia 1
Totale 1.265
Città #
Chandler 182
Southend 179
Frankfurt am Main 171
Seattle 34
Princeton 30
Wilmington 27
Fairfield 25
Milan 25
Dublin 21
Ann Arbor 20
Munich 17
Brussels 13
Phoenix 13
Des Moines 12
Houston 11
Nanjing 11
Ashburn 10
Falls Church 10
Woodbridge 10
Beijing 9
Bengaluru 7
Cambridge 7
Hong Kong 7
Jinan 7
Redwood City 6
San Diego 6
Boardman 5
New York 5
Shenyang 4
Tokyo 4
Amsterdam 3
Aprilia 3
Changsha 3
Chicago 3
Lessolo 3
London 3
Piacenza 3
Seoul 3
Toronto 3
Ancona 2
Buffalo 2
Chengdu 2
Diyarbakir 2
Florence 2
Formia 2
Haikou 2
Hangzhou 2
Hanoi 2
Hefei 2
Helsinki 2
Ipswich 2
Jiaxing 2
Kunming 2
Molteno 2
Mountain View 2
Mumbai 2
Rome 2
Taranto 2
Almere Stad 1
Andover 1
Athens 1
Baltimore 1
Berlin 1
Bitonto 1
Brugine 1
Central District 1
Cleveland 1
Concesio 1
Düsseldorf 1
Freitas 1
Fremont 1
Fuzhou 1
Haifa 1
Hebei 1
Huntington 1
Kuala Lumpur 1
Medford 1
Oslo 1
Ottawa 1
Polska 1
Puebla City 1
Quito 1
Salem 1
San Francisco 1
Silver Spring 1
Taiyuan 1
Takamatsu 1
Thessaloníki 1
Tianjin 1
Venezia 1
Vienna 1
Zhengzhou 1
Totale 987
Nome #
Corrigendum to “Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica” (Critical Reviews in Oncology / Hematology (2019) 137 (154–164), (S1040842819300587), (10.1016/j.critrevonc.2019.03.006)) 177
Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma 108
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors : implications for clinical practice, trial design, and molecular interrogation 100
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma 98
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial 96
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma : a systematic review and meta-analysis of patient outcomes 89
Quality of life and pain control following laparoscopic retroperitoneal lymph node dissection in early-stage nonseminoma. 87
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica 87
Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomes 86
Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy 84
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer 82
Persistent CD30 expression by embryonal carcinoma in the treatment time course: prognostic significance of a worthwhile target for personalized treatment 80
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer : an open label, single-group, phase 2 trial 73
Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancer 70
Biomarker-driven immunotherapy for precision medicine in prostate cancer 50
Totale 1.367
Categoria #
all - tutte 3.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 2 11 1 7 7
2019/2020105 15 1 4 7 2 4 7 9 26 18 7 5
2020/2021138 47 8 6 4 22 10 9 14 9 4 1 4
2021/2022203 6 5 8 7 12 16 7 6 10 20 24 82
2022/2023351 45 55 38 54 13 48 7 21 55 4 8 3
2023/2024242 15 6 18 19 62 7 65 50 0 0 0 0
Totale 1.367